3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Other
1
Conditions
Leukemia, Myeloid, Acute
272
Leukemia
194
Precursor Cell Lymphoblastic Leukemia-Lymphoma
131
Lymphoma
108
Congenital Abnormalities
68
Myelodysplastic Syndromes
63
Leukemia, Myelomonocytic, Acute
60
Leukemia, Monocytic, Acute
58
Leukemia, Erythroblastic, Acute
56
Leukemia, Megakaryoblastic, Acute
54
Lymphoma, Non-Hodgkin
51
Burkitt Lymphoma
44
Lymphoma, Mantle-Cell
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
33
Leukemia, Myelomonocytic, Chronic
28
Anemia, Refractory, with Excess of Blasts
27
Hodgkin Disease
26
Recurrence
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Lymphocytic, Chronic, B-Cell
25
Blast Crisis
24
Leukemia, Eosinophilic, Acute
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
18
Myeloproliferative Disorders
17
Leukemia, Basophilic, Acute
17
Lymphoma, B-Cell, Marginal Zone
16
Leukemia, Promyelocytic, Acute
16
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Accelerated Phase
14
Interventions
Radiotherapy
6
Fibroblast Growth Factor 7
4
Injections
3
Drug Therapy
3
Cisplatin
3
Water
2
Propolis
2
Mouthwashes
2
Morphine
2
Methotrexate
2
Melphalan
2
Low-Level Light Therapy
2
Interleukin 1 Receptor Antagonist Protein
2
Gabapentin
2
Cryotherapy
2
peppermint oil
1
pegaspargase
1
oxycodone-acetaminophen
1
nelarabine
1
kang-lai-te
1
glucarpidase
1
fludarabine phosphate
1
fish oil triglycerides
1
cyclohexaneacetic acid
1
calcium phosphate
1
brilacidin
1
anise oil
1
amlexanox
1
aluminum hydroxide, magnesium hydroxide, drug combination
1
acetaminophen, hydrocodone drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Mucositis
×
Cytarabine
×
Clear all
NCT01085617
2025-03-30
UKALL14
University College, London
Completed